Response depends on genetics, biomarkers, adherence, and individual physiology together
However, as more individuals use the medications, several serious health risks have been linked to GLP-1s, including a severe form of stomach paralysis known as gastroparesis, intestinal obstructions and a rare vision condition known as nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blurred vision or blindness
doi: 10.1111/dom.14944
Combining GLP-1 agonists with traditional methods can: Enhance results : Medications can jumpstart weight loss, while lifestyle changes ensure long-term maintenance
Six participants were included in the ITT but excluded from the per-protocol (PP) analysis because they did not satisfy the definition of full adherence and therefore did not meet the conditions to be included in PP analysis
As your weight stabilizes and your body adapts to its new composition, your temperature regulation often improves